Evolent Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Evolent Health, Inc. on March 31, 2021. The report details the consummation of a previously announced transaction involving the company and its subsidiaries.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a corporate event rather than periodic financial performance.
Material Changes
On March 31, 2021, Evolent Health, Inc. and its subsidiaries consummated the transactions contemplated by the Stock Purchase Agreement dated January 11, 2021. The agreement was between Evolent Health, LLC, EH Holding Company, Inc., True Health New Mexico, Inc., and Bright Health Management, Inc.
Guidance, Outlook, and Risks
The filing text does not provide forward-looking guidance, management commentary on future outlook, specific risk factors, or details on contingencies related to this transaction.
Key Facts for Investor Verification
- Verify the final terms and consideration paid in the Stock Purchase Agreement with Bright Health Management, Inc.
- Confirm the impact of the True Health New Mexico, Inc. acquisition on Evolent Health's consolidated financial statements in the subsequent 10-Q or 10-K.
- Review the original January 11, 2021, announcement for details on the strategic rationale not included in this 8-K.